Rebiotix
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2660 Patton Rd, Roseville, Minnesota, 55...Phone Number
(651) 705-8770Website
www.rebiotix.comRevenue
$13.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rebiotix
Rebiotix Inc., now part of Ferring Pharmaceuticals, focuses on developing innovative microbiome-based therapies. Their primary aim is to address unmet medical needs by leveraging the microbiome's potential in treatment. The company targets healthcare providers and patients in the medical community. Through their donor program, they engage with donors to advance their research and therapy developments.Explore more
Rebiotix Org Chart
Get the full picture
Sign in to uncover key details.
DM
Senior Director, Quality
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rebiotix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Rebiotix has new funding data
Earning: See what the market has to say on Rebiotix recently announced quarterly report
Click to see if Rebiotix had a recent Job posting/layoffs
Check if Rebiotix has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Rebiotix
Product Launch: Get notified when Rebiotix launches new products
Check out if Rebiotix is spiking on competitors!
Rebiotix, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Rebiotix
Compare insights from companies similar to Rebiotix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rebiotix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rebiotix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rebiotix.
Rebiotix financials insights
Gather financial insights about Rebiotix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$2.8M
Series A
$2.8M
2014
Series B
$18M
2017
Debt
$8.5M
Rebiotix Tech Stack
A closer look at the technologies used by Rebiotix
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Project
employees have conducted significant online research into email deliverability during the week of 03/16/2018, indicating an increased focus in this area. Kathleen (Kathy) Leith serves as Director, Marketing.
Collaboration/Web Apps, Request for Proposal (RFP), Email
Funding
Rebiotix is raising $10 million in a funding round.
Funding
Funding
Funding
Rebiotix News & Media
Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021Ferring to Present Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection and IBD at ACG 2021
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring to Present Award-Winning, Real-World Outcomes Analysis for RBX2660 in Patients with Recurrent C. Difficile Infection and IBD at ACG 2021Ferring Presents Complete Data across Five RBX2660 Trials Demonstrating Consistent and Durable Efficacy in Recurrent C. Difficile Infection, as Well as Multiple Analyses Demonstrating Positive Shifts in Microbiome Properties
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring presents data across five RBX2660 trials in recurrent C. difficile infection, and analyses showing positive shifts in microbiome propertiesFerring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring to Present Award-Winning, Landmark Research for Investigational Microbiota-Based Live Biotherapeutic RBX2660 at IDWeek 2021
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rebiotix
Sign Up For FreeTo access detailed company insights
Rebiotix Inc., now part of Ferring Pharmaceuticals, focuses on developing innovative microbiome-based therapies. Their primary aim is to address unmet medical needs by leveraging the microbiome's potential in treatment. The company targets healthcare providers and patients in the medical community. Through their donor program, they engage with dono... Read More
